Atlas Trials

Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women

Clinical trial NCT05630768 · COMPLETED

Trial details

NCT number
NCT05630768
Sponsor
Dong-A ST Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Postmenopausal Osteoporosis
Start date
2023-01-03
Primary completion
2025-07-23
Enrollment
149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.